Debbie Wasserman Schultz actually said...

This program is supposed to be used to protect patient safety.

the FDA very specifically said that they did not think that providing samples to generic manufacturers would create a safety concern.

Prevention of generic encroachment just means to delay generic competition.

Congress has created--has acted to address inappropriate usage of safety programs through the CREATES Act last year.